Lorazepam

Product NDC
65219-368
11-digit product format
652190368
Labeler code
65219
Product ID
65219-368_462a13da-259a-40e7-bd5b-f7f42ae025b7
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Lorazepam
Dosage form
INJECTION
Route
INTRAMUSCULAR; INTRAVENOUS
Labeler
Fresenius Kabi USA, LLC
Application
ANDA217598
Marketing category
ANDA
Marketing start
2024-12-13
Substance
LORAZEPAM
Active strength
2 mg/mL
Pharmacologic classes
Benzodiazepine [EPC], Benzodiazepines [CS]
DEA schedule
CIV
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A217598-001LORAZEPAMLORAZEPAM2MG/MLINJECTABLE / INJECTIONAP2024-11-18

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-productTE code
A217598-001AP

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-08-18 06:07:402026-07A217598-001LORAZEPAM2MG/MLINJECTABLE / INJECTIONAP2024-11-18caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A217598-001LORAZEPAM2MG/MLINJECTABLE / INJECTIONAP2024-11-18011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A217598-001LORAZEPAM2MG/MLINJECTABLE / INJECTIONAP2024-11-1831067a03dcf5…
2025-08-23 18:47 UTC2025-08A217598-001LORAZEPAM2MG/MLINJECTABLE / INJECTIONAP2024-11-186a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A217598-001LORAZEPAM2MG/MLINJECTABLE / INJECTIONAP2024-11-18fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A217598-001LORAZEPAM2MG/MLINJECTABLE / INJECTIONAP2024-11-18b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A217598-001LORAZEPAM2MG/MLINJECTABLE / INJECTIONAP2024-11-1803ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A217598-001LORAZEPAM2MG/MLINJECTABLE / INJECTIONAP2024-11-182680178bc6a6…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A217598-001LORAZEPAM2MG/MLINJECTABLE / INJECTIONAP2024-11-18a50c72e98297…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-08-18 06:07:402026-07A217598-001AP1caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A217598-001AP1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A217598-001AP131067a03dcf5…
2025-08-23 18:47 UTC2025-08A217598-001AP16a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A217598-001AP1fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A217598-001AP1b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A217598-001AP103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A217598-001AP12680178bc6a6…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A217598-001AP1a50c72e98297…

Additional Listing Data#

Finished product
Yes
Brand name base
Lorazepam
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
LORAZEPAM2 mg/mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
O26FZP769LInternal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
1665188Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
462a13da-259a-40e7-bd5b-f7f42ae025b7Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
a759f740-8682-4896-9194-8b6c103c9aeeProduct name320250716
b7badb1c-6d3f-4f95-a4ca-ce69992e58a1Product name120220308
5d98a0ba-a64b-d9b2-e6ec-87edbb57a285Product name220180320
9869efd7-d6dd-0665-5b67-53adbe6ef15eProduct name120140508
ac8efea8-f412-295f-00ce-b095e5cbc115Product name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
65219-368-01Lorazepam1 mL in 1 VIALINJECTION11
65219-368-02Lorazepam25 in 1 TRAYINJECTION251
65219-368-14Lorazepam1 mL in 1 VIALINJECTION11
65219-368-24Lorazepam25 in 1 TRAYINJECTION251

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
65219-368-01ML - Milliliter65219-3686fc4c7ec-6971-4f6e-b8ae-30fac27f324412024-12-10
65219-368-02ML - Milliliter65219-36882ed6995-7ecf-422b-a479-a979565e4b8512024-12-10

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
65219-368LORAZEPAM INJECTION [FRESENIUS KABI USA, LLC]1Current NDC, 2 package rows20241213_b2487467-a63f-48b5-b0de-3a6ce6672d50.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
LorazepamLORAZEPAMFresenius Kabi USA, LLC462a13da-259a-40e7-bd5b-f7f42ae025b72026-03-13Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 217598
application number: ANDA217598
ndc (product): 65219-368
LorazepamLORAZEPAMFresenius Kabi USA, LLCb2487467-a63f-48b5-b0de-3a6ce6672d502024-11-26Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 217598
application number: ANDA217598
ndc (product): 65219-368

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
1665188LORazepam 2 MG in 1 ML InjectionPSN462a13da-259a-40e7-bd5b-f7f42ae025b71
1665188LORazepam 2 MG in 1 ML InjectionPSNb2487467-a63f-48b5-b0de-3a6ce6672d501
16651881 ML lorazepam 2 MG/ML InjectionSCD462a13da-259a-40e7-bd5b-f7f42ae025b71
16651881 ML lorazepam 2 MG/ML InjectionSCDb2487467-a63f-48b5-b0de-3a6ce6672d501
1665188lorazepam 2 MG per 1 ML InjectionSY462a13da-259a-40e7-bd5b-f7f42ae025b71
1665188lorazepam 2 MG per 1 ML InjectionSYb2487467-a63f-48b5-b0de-3a6ce6672d501

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startSampleExclude flagStatus
65219-368-01652190368011 mL in 1 VIAL1 mlHistorical
65219-368-026521903680225 VIAL in 1 TRAY (65219-368-02) / 1 mL in 1 VIAL (65219-368-01) 25 vial2024-12-13NoNoCurrent
65219-368-14652190368141 mL in 1 VIAL1 mlHistorical
65219-368-246521903682425 VIAL in 1 TRAY (65219-368-24) / 1 mL in 1 VIAL (65219-368-14) 25 vial2024-12-13NoNoCurrent